Patents/Inventors

Renaud Buffet

BoulogneFR1 patent

2 Patents

US120844982024
Compound That Specifically Binds to KIR3DL2 for Use in the Treatment of Peripheral T Cell Lymphoma
INNATE PHARMA
0 cites
US119997842024
Treatment of Peripheral T Cell Lymphoma
INNATE PHARMA
0 cites